BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 34985760)

  • 1. Risk factors of developing contralateral breast cancer after first primary breast cancer treatment.
    Avatefi M; HadavandSiri F; Nazari SSH; Akbari ME
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1927. PubMed ID: 37919558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonaspirin NSAIDs and contralateral breast cancer risk.
    Bens A; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Friis S; Mellemkjaer L
    Int J Cancer; 2019 Mar; 144(6):1243-1250. PubMed ID: 30362513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
    Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
    Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
    Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
    J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality after contralateral breast cancer in Denmark.
    Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
    Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
    Bens A; Dehlendorff C; Friis S; Cronin-Fenton D; Jensen MB; Ejlertsen B; Lash TL; Kroman N; Mellemkjær L
    Br J Cancer; 2020 Mar; 122(7):1102-1108. PubMed ID: 32063603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-blockers and risk of contralateral breast cancer.
    Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
    Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis.
    Caparica R; Bruzzone M; Agostinetto E; De Angelis C; Fêde Â; Ceppi M; de Azambuja E
    ESMO Open; 2021 Apr; 6(2):100066. PubMed ID: 33639601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contralateral breast cancer: metastasis or second primary cancer?].
    Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
    Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.